Mamoru Ohashi

Title: Mamoru Ohashi: Innovator in Pharmaceutical Composition

Introduction

Mamoru Ohashi is a notable inventor based in Amagasaki, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of rapidly soluble and stable drug compositions. His work has led to advancements that enhance the bioavailability and dissolution characteristics of pharmaceutical compounds.

Latest Patents

Ohashi holds 2 patents, with his latest innovations focusing on two key pharmaceutical compositions. The first is a rapidly soluble drug composition, which includes micronized (R)-2-(4-bromo-2-fluorobenzyl)-1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine-4-spiro-3'-pyrrolidine-1,2′,3,5′-tetrone, referred to as AS-3201. This composition is designed to improve dissolution characteristics and bioavailability. The second patent is for a stable drug composition that incorporates AS-3201 along with a stabilizer, which can be an acidic substance such as ascorbic acid or citric acid, enhancing the stability of the pharmaceutical formulation.

Career Highlights

Throughout his career, Mamoru Ohashi has worked with prominent companies in the pharmaceutical industry, including Dainippon Pharmaceutical Company, Limited and Dainippon Sumitomo Pharma Co., Ltd. His experience in these organizations has contributed to his expertise in drug formulation and development.

Collaborations

Ohashi has collaborated with notable colleagues such as Kazuyoshi Ogasawara and Yoshimi Shirai. These partnerships have facilitated the exchange of ideas and innovations in the pharmaceutical field.

Conclusion

Mamoru Ohashi's contributions to pharmaceutical compositions demonstrate his commitment to improving drug efficacy and stability. His patents reflect a deep understanding of the complexities involved in drug formulation, making him a significant figure in the industry.